Analytical Data
-
Gene name
ARL11
- Application
-
Alternative Names
ARL11；ARLTS1；ADP-ribosylation factor-like Protein 11
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q969Q4
-
Expression Region
1-196aa
-
AA Sequence
MGSSHHHHHH SSGLVPRGSH MGSVNSRGHK AEAQVVMMGL DSAGKTTLLY KLKGHQLVET LPTVGFNVEP LKAPGHVSLT LWDVGGQAPL RASWKDYLEG TDILVYVLDS TDEARLPESA AELTEVLNDP NMAGVPFLVL ANKQEAPDAL PLLKIRNRLS LERFQDHCWE LRGCSALTGE GLPEALQSLW SLLKSRSCMC LQARAHGAER GDSKRS
-
Molecular Weight
24 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ARL11, a member of the ADP-ribosylation factor-like (ARL) protein family, has garnered attention in recent years due to its potential roles in cellular signaling, membrane traffic, and cytoskeletal organization. Its involvement in various cellular processes makes ARL11 an intriguing subject for research, particularly in the context of diseases such as cancer and neurological disorders, where dysregulation of ARL proteins has been implicated. Studies have suggested that ARL11 may interact with specific binding partners to influence the dynamics of intracellular transport and organelle function. However, the exact mechanisms by which ARL11 exerts its effects and the full spectrum of its physiological roles remain poorly understood. Recent advances in protein engineering and structural biology techniques have opened new avenues to explore ARL11's function at a molecular level, including the potential to develop ARL11-based therapeutic strategies. Understanding the intricate pathways modulated by ARL11 can not only shed light on fundamental biological processes but also pave the way for innovative approaches in the treatment of ARL11-related pathologies. As such, the study of recombinant ARL11 has become a focal point for researchers aiming to elucidate its functional landscape and therapeutic potential in human health.
